Supplementary Materials and Methods

Development of the vector pCLIIP for transposase generation of stable cell lines.
The basis of the piggyBac transposon vector pCLIIP was pCYL50 (kindly provided by Allan Bradley, Sanger Institute, UK) and was constructed in four steps. In an attempt to reduce variability in transgene expression levels following the stable integration of the final construct in transfected cells, we positioned two HS4 insulator elements (each element comprising two 250bp HS4 core elements, Felsenfeld lab) either side of a custom polylinker. This was achieved by cloning the first HS4 element as a EcoRI-BamHI fragment into EcoRI and BamHI sites in the pCYL50 polylinker. We then inserted our own polylinker into the EcoRI site of pCYL50 by annealing the following complimentary oligos.
Sense; 5' AATTGAATTCAGGAGATCTACGCGTCAATTGGGCCGGCC 3' Antisense; 5' AATTGGCCGGCCCAATTGACGCGTAGATCTCCTGAATTC 3' This linker destroyed the recipient EcoRI site used in the cloning step, but To make pCLIIP-C-LS we cloned a CAGGS promoter as a 1.7kb PCR product with EcoRI ends into the unique MfeI site in the polylinker of pCLIIP. prCAGGS 5'; 5' GATGAATTCCGACATTGATTATTGACT 3' prCAGGS 3'; 5' GCCGAATTCCTTTGCCAAAATGATGAG 3' Finally, we cloned a Luciferase2-E2A-mStrawberry-pA fragment (previously constructed by S Lyons, unpublished) following PCR amplification using primers with FseI ends into the unique FseI site in the polylinker of our vector. prLuc2-FP 5'; 5' AATTAAGGCCGGCCACCATGGAAGATGCCA 3' prLuc2-FP 3'; 5' AATTAAGGCCGGCCTCAGAAGCCATAGAGCC 3' All steps were verified by sequencing.
Preparation of Luciferase2 and mStrawberry (LS) expressing fibrosarcomas. SV40
and hRAS transformed embryonic fibroblasts (1) expressing single VEGFA isoforms through genetic alteration of the endogenous vegfa gene were prepared 4 as follows: 1 x 10 5 of each fibrosarcoma cell line were seeded overnight in 6 well plates before the medium was changed. 1 µg of pmPB (kindly provided by Allan Bradley, Sanger Institute, UK) and pCLIIP-C-LS were transfected using Lipofectamine 2000 (Invitrogen) overnight before the cells were expanded into T175 flasks. mStrawberry positive cells were put through 3 rounds of FACS using a BD FACS ARIA. The resulting cell lines were > 95% positive for mStrawberry.
Bioluminescence output per cell (p/s/cell) was measured by plating serial dilutions of the fs-LS cell lines in black 96 well plates in 100 µl complete medium and adding 50 µl D-Luciferin (0.6 mg/ml) immediately before measurement on an IVIS Lumina II (Perkin Elmer). Bioluminescence output was 2.8, 3.6, 3.2 and 4.6 x 10 3 p s -1 cell -1 for fs120-LS, fs164-LS, fs188-LS and fsWT-LS respectively. No significant difference in tumor growth was observed between the parental lines and the LS derivatives (data not shown). Cell lines were validated in house at passage 8 and then used to a maximum of passage 30 (typically 2-3 months).
Correct VEGFA isoform expression, SV40 and hRAS expression levels, maintenance of cell morphology at low density and population doubling times were confirmed as we described before (Kanthou et al, PloS). The cells were also free of mycoplasma. Bioluminescence measurement of the thoracic region of mice was made 10 min after luciferase injection using an IVIS Lumina II (Perkin Elmer).
Bioluminescence output (p/s/cm 2 /sr) of the thoracic region was measured using the Living Image TM software (Perkin Elmer) after drawing an appropriate region of interest (ROI). For imaging of excised lung lobes on necropsy, mice were anaesthetized and injected with D-luciferin as described above, before being killed. Lungs were excised and dissected into individual lobes, placed on a square of black plastic and imaged in the IVIS Lumina II for analysis of bioluminescent output. Bioluminescence output (p/s/cm 2 /sr) of the individual lobes was measured after drawing an ROI around each lobe with the final measurement the sum of all five lobes.
Preparation of cell conditioned medium for injection into mice. Fs120 cells were seeded into T175 flasks and grown to 70-80% confluence before the cells were washed 3 x with antibiotic and serum free medium. As fs120 tumors have significant levels of necrosis that could indicate significant areas of hypoxia (3) and this is a major regulator of VEGFA and PlGF2 expression, cells were incubated in 10 ml of antibiotic and serum free medium in separate flasks in either atmospheric O2 or 1% O2 for 24 h before the medium was combined. The cell-conditioned medium was centrifuged at 10,000 x g in a micro-centrifuge before the supernatant was filtered through a 0.2 µm membrane filter and stored at -80°C. cell conditioned medium or control medium was injected ip once per day for 6 days at 200µl/20g mouse before iv injection of 5 x 10 4 fs120-LS cells to examine cell survival in the lungs as described previously. Perivascular cell coverage was analysed using FFPE embedded material as this improved their visualization. Vessels were detected using CD34 as the anti-CD31 antibodies we had previously characterized by IHC did not work using immunofluorescence. CD31 +VE vessels showed a very high degree of overlap with CD34 on immunofluorescence staining in frozen sections and virtually the same vessel number when counted per high-powered field of view (Supplementary Fig   S1) . For co-staining of CD34 +VE blood vessels and αSMA +VE perivascular cells, FFPE sections were cut as described above followed antigen recovery after dewaxing in citrate buffer, pH6 by heating in a 900 W microwave at full power For confocal imaging of fibrosarcoma cells and CD31 within lung tissues, frozen lung sections were stained with the antibodies described above and the appropriate Alexa488/555 conjugated secondary antibodies before mounting.
Images were captured using a laser scanning Zeiss LSM510 NLO Inverted confocal microscope with a 40 x 1.3 NA oil immersion lens with an optimal pinhole setting for capturing optical slices.
Transwell migration assays. 8 μm pore size cell culture transwell inserts for 24 well plates (BD biosciences) were coated with 100 μl of 200 μg/ml laminin or 100 μg/ml collagen or in sodium carbonate buffer (Sigma) pH 9.8 for 16 h at 37°C on the upper surface. Cells were serum starved for 6 h in serum free growth medium before seeding 2.5 x 10 4 cells in 500 µl in the transwell insert. 800 µl DMEM containing 10% v/v FBS was added to the well of the plate as a chemoattractant before incubating for 24 h at 37°C. 10 µg/ml B20-4.1.1 or control IgG BE5 (Genentech Inc. San Francisco, USA) were added in both the upper and lower chambers. Cells remaining in the upper chamber of the transwell were removed with a cotton bud before the inserts were fixed in methanol for 5 min at -20°C and left to dry. The membranes from each insert were removed and mounted on Menzel-Gläser Superfrost ® glass slides (Thermo-fisher Scientific) in Vectashield ® mounting medium (Vector labs) containing DAPI and sealed with a coverglass. Slides were stored in -2°C to -8°C in the dark. Images of 4 separate fields of view per membrane for 4 transwells were taken with an inverted microscope (DMI4000b, Leica) using a 10 x 0.3 NA objective (Nikon) and the LASAF software for data capture. Image analysis and cell counting was 11 performed using Image J. The experiment was performed 3 times to ensure data obtained were representative.
Single cell migration using live video microscopy. Optimal coating concentrations of tissue culture plastic was first determined by measuring adhesion of cells on increasing concentrations of collagen-I and laminin in 96 well plates to determine the point at which maximal adhesion was reached. For live video experiments, wells of 12 well plates were coated with 1 ml per well of 20 μg/ml of collagen-1 in 0.02N acetic acid or 5μg/ml of laminin-1 in PBS at room temperature for 2 h. Coated wells were then washed with 1 ml of PBS before rinsing with culture medium. 5 x 10 3 of either fs120 or fs188 were seeded in 1 ml of culture medium per well of a 12-well plate overnight in culture medium as described previously. Prior to transfer to the microscope for live image capture, the medium was exchanged with fresh medium containing either 20 µg/ml of the anti-VEGFA antibody B20-4.1.1 or the control IgG BE5. The cells were allowed to equilibrate within the humidified chamber of the AF6000 time-lapse microscope (Leica, Milton Keynes) at 37°C, 5% CO2 for 2 h before commencing image capture using a 20 x objective and the LAS AF software (Leica, Milton Keynes). 2 positions per well were used across three separate well and images for each position were taken every 15 mins. The duration of imaging was 5 h. The Manual Tracking Tool, produced by Image J, was used to track the path of cell migration.
The migration distance and speed were then calculated with the ImageJ Chemotaxis Tool (Ibidi) using the coordinates generated by the manual-tracking tool. A minimum of 30 cells was tracked within each experimental condition.
Tracks from cells undergoing mitosis during imaging were excluded.
Western blotting of tumor lysates. 10 mm 3 pieces of tumors were cut into smaller pieces before homogenisation in an IKA Ultraturrax homogeniser using ice cold radioimmunoprecipitation assay (RIPA) buffer (Thermofisher) containing Complete TM proteinase inhibitor cocktail (Roche) and phosphatase inhibitor cocktail II at 2 x the recommended concentration. Homogenates were passed sequentially through 19 -30 gauge needles on ice before centrifugation at 10,000 x g for 5 min at 4°C to remove debris. Protein concentration of the supernatant (lysate) was measured using a micro BCA assay kit (Thermofisher).
5 µg of each tumor lysates was resolved on 8% w/v reducing (laminin) or nonreducing (collagen-I) Tris-Glycine SDS page gels before transferring to nitroceullulose membranes using a semi-dry transfer system (Invitrogen).
Membranes were blocked with 5% w/v fat free milk powder (Marvel) in Trisbuffered Saline (TBS) with 0.1% Tween-20 v/v for 30 min. Antibodies were used according to the manufacturers' instructions. Anti-collagen-I was purchased from Millipore (AB765P, 1:500) and pan-laminin and GAPDH antibodies from Abcam (AB11575, and AB9484 both 1:5000). Detection was with the appropriate HRP-conjugated secondary antibody (Dako) and enhanced chemiluminescence substrate (ECL) and film. Densitometry of collagen-I (aggregates, dimers and monomers) and laminin for each tumor lysates was performed using the Image studio Lite software (LiCor, Cambridge). This was normalised for loading after the membrane was stripped using Restore western blot stripping solution (Thermofisher, UK), re-probed with anti-GAPDH. Data was also normalised against a common reference sample included with each 13 separate gel made from multiple pooled tumor lysates to correct for small differences in ECL intensity across separate Western Blots.
Angiogenesis array analysis of 3D multicellular spheroids. Cells were seeded at 1 x 10 4 cells/well in 150 μl growth medium containing 5% v/v methocellulose solution in u-bottom 96 well suspension culture plates (Greiner). After 5 days, a further 100 μl of spheroid culture medium was added to each well. Plates were incubated for an additional 2 days. Spheroids were harvested by pipetting cells from the 96 well plate followed by centrifugation for 5 min at 800 x g and washed in ice cold PBS. The spheroid pellet was then incubated in 250 μl RIPA buffer containing the proteinase and phosphatase inhibitor cocktail described above for 10 min on ice. The spheroid pellet was then lysed and dissociated by syringing sequentially through 21 to 30 gauge needles and debris removed by centrifugation at 10,000 x g in a microfuge at 4°C before protein concentration was measured using a micro BCA assay kit (Thermofisher). 200 µg lysate was incubated on the Proteome Profiler Mouse Angiogenesis Array kit following the manufacturers' instructions (R&D Systems). Western Sure ® Premium Chemiluminescent (LiCor, Cambridge) substrate was used to detect spots on a Cdigit ® blot scanner (LiCor, Cambridge) with the images being acquired using Image Studio software (LiCor, Cambridge). The signal and background was adjusted using Image studio software (LiCor, Cambridge) and normalised using the control spots on each membrane.
Statistical analysis. Data was plotted and analysed using GraphPad Prism 6.0e (GraphPad Prism Software Inc). Pair-wise analysis of data with a normal distribution was made using an unpaired Student's t-test with a Welch's correction. Pair-wise comparisons for data that did not have a normal distribution were made using a Mann-Whitney test. For analysis of three or more groups, data having a normal distribution was analyzed using ANOVA followed by Sidak's multiple comparison test for key pair-wise comparisons. For data that did not follow a normal distribution, a Kruskal-Wallis test followed by a Dunn's multiple comparison test for key pair-wise comparisons was used. Kaplan Meier analysis was used to analyze differences in time to reach a pre-determined humane end point as a surrogate for survival. For subcutaneous tumor growth this was set at ≥1000 mm 3 and for live bioluminescence imaging this was set to ≥1x10 7 p/s within the thoracic region. In some experiments, data were combined from more than one cohort of mice to reach statistical power and to ensure similar data was obtained from separate litters. Where data were obtained from more than one cohort, data was normalized against the mean of a common parameter before statistical analysis, as indicated in the figure legends.
Experiments comparing VEGFR1-WT and VEGFR1-ΔTKD mice were conducted using littermates from the same cohort.
